Skip to content

Our Services

We provide bespoke strategic solutions for Biotechs, Pharmas and CROs worldwide. We listen to our clients’ needs and provide personalised, tailored solutions, drawing from our global force of esteemed industry professionals. Our network is flexible, capable and always ready for the next challenge.

How We Can Help Your Project?

Our consultants can enrich your research programme at multiple points of the study lifecycle. There is no prescribed methodology: we pride ourselves on delivering a wide array of main and niche services meaning you only pay for what you need.

We strive to deliver a solution for your specific requirements – no task is too small or too big. Thanks to the unique Momentum Pharma model, our services are always relevant to the skills you’re seeking. No cross-charging or unnecessary overheads for services that aren’t of use.

Momentum Pharma was established in 2013 by Melissa and Jon Melton with the aim of bringing a fresh and agile way to partner with Biotech and Pharmaceutical companies. We are passionately driven to work intelligently and as fast as possible to advance the development of new treatments for patients in need.

Our Story is not ours alone. It is shared by our global experts whose commitment to science and doing things right is the key to advancing clinical trials into real treatment options.

OUR SERVICES

We provide a variety of traditional outsourced services to meet your needs. These are designed to build a solid foundation for your study, ensuring you have a smooth path to success.

Quality Control Visits
Our Quality Control Monitors provide essential CRO oversight, assessing the proficiency of the CRO monitor to conduct assigned tasks and adherence to the Clinical Monitoring Plan. They also report on the compliance of the site according to ICH-GCP, inclusion exclusion criteria, safety monitoring and risk assessment.
Project Management
Our experienced project managers can initiate, plan, execute, control and close a study in line with your goals and specific success criteria. We have a global focus, allowing us to deliver project managers for both US-based and international clinical trials.
Senior Level CRAs
Experts in their local territory and regulations, our senior-level CRAs can give you unrivalled insights into key regions. Each has an average of 15 years’ experience; many are multi-lingual and can monitor across different countries.
Medical Monitor
Our experienced pharmaceutical physicians uphold the highest standards of medical support, interim management and emergency intervention. They are experienced in medical affairs and clinical development, with a wide array of disease indications.
Regulatory Services
We can perform your National Competent Authority and Ethics submissions and support all regulatory services throughout the lifecycle of your study. Our experts can guide you on New Clinical Trials Regulations and the EU Voluntary Harmonisation Procedure.
Inspection Readiness
We take the stress out of auditing, with resources to conduct GCP Investigator Site audits (Phase I–IV), Vendor Qualification and In-process audits, Internal Process, GMP and GLP audits, and Gap Analysis. We can also support GCP and Site Management training, Mock Inspections, Inspection Preparation, Assists at Inspections and advice on inspection responses.
Rescue Teams
If an issue occurs, we can jump in and support you with a co-monitoring service. We can help you quickly identify experienced consultants who can steer you through a busy or rough period for a short term or even longer duration, if needed.
Medical Writing
Our medical writers focus on Study Protocols, Patient Information Leaflets, Clinical Study Reports, Manuscripts, Product Monographs, Paediatric Investigational Plans, Risk Management Plans, Press Releases and Clinical Summaries, to name a few.
Supplementary Main Services
We fill all types of unique roles for our clients, from report reviews and quality management to site feasibility and study activation roles.
DOWNLOAD OUR BROCHURE

The Momentum Pharma Difference

We present bespoke options for our Sponsors that are cost effective, quality driven and different from the typical CRO.

We started Momentum Pharma because we could clearly see a better way forward and a different model in clinical research. We have total commitment to transparency, fair pricing, quality and responsibility for your study.

Our goal is to be a true partner and an extension to the Sponsor’s team rather than just another CRO. Thanks to the fully outsourced model that Momentum Pharma has implemented from the inception of our company, we are able to select hand-picked teams in each relevant country. The consultants we will select for your project will have a longevity in clinical research, with proven history, reputations and skill set that will match your program’s requirements precisely.

Unparalleled Consultants

We understand our client base because we’ve been them.

Teams All Over The World

Our therapeutic area expertise is both deep and diverse.

Our Cost Efficient Model

Our clients are allocated with the most adept, efficient resources.

Flexible and Fast Responses

We’re better able to focus on a tactical “plan of action”.

Ongoing
Dialogue

Our therapeutic area expertise is both deep and diverse.

Jarmila Yu

Jarmila Yu is an award-winning globally ranked Top100 Chief Marketing Officer, she is a Chartered Marketer and Fellow of both the Institute of Data and Marketing and the Chartered Institute of Marketing. She has over 25 years of experience working with fast paced pioneering IT and professional services companies, ranging from start-ups to blue chips in B2B and B2C.

Jarmila is an entrepreneurial marketing strategist who has a passion for innovation, and a track record for growing and transforming business through efficient, effective, and impactful marketing. Her role as CMO for Momentum Pharma is to ensure the marketing and brand is fit-for-purpose, enabling the company to deliver on its mission to provide the highest calibre of excellence to support its clients in continuing to make medical breakthroughs that improves the quality of life and saves lives. 

Cindy Abbas

Cindy is Momentum Pharma’s Administration Manager and joined the company in May 2016 where she performs many roles for the firm.  These include corresponding with Sponsors and the Consultants on contractual administration, checking and organising the submission of monthly invoices and expenses of the Consultants.  Cindy is the principal controller for the Momentum Pharma Database.

Cindy started her career in 1989 and has a strong Accounting and Finance background. She has worked for Global Financial companies in a number of roles including; Team Leader in the Accounting Department and Account Manager for a large US based client.

Matthew Melton

Matthew is Momentum Pharma’s Chief Information Officer. He created the bespoke Database and other platforms that the firm uses. Matthew has an engineering and IT background with a broad technical base.

Matthew has worked in the medical device field during his time with a UK engineering company where he programmed the Hardware Control and UI Software design for the NT1000 radio-frequency generator for Thermal Lesioning medical equipment within an ISO 9001:1994 ‘Quality Systems Manufacturing Environment’. 

Matthew’s technical skills include electrical and electronic software engineering, systems design and administration.  He holds a MSc in Computing and a BEng in Electronic Engineering from Cardiff University of Wales. 

Ieva Marshall

Ieva oversees the operational functions of Momentum Pharma, working closely with the CEO, COO, CIO, and the wider leadership team to drive efficiency and alignment across the business.

Her role spans a wide range of internal processes and strategic initiatives, ensuring operations run smoothly while supporting the company’s growth ambitions. By embedding best practices and fostering collaboration between teams, Ieva helps maintain strong operational foundations that keep Momentum agile and responsive to business needs.

Ellesha Nicholas

Joined Momentum Pharma in February 2023.  Ellesha liaises with Consultants, Sponsors and the internal team to ensure smooth execution of organisational operations and initiatives. She is responsible for streamlining business processes and works collaboratively within the team to drive operational excellence and organisational growth

Ellesha graduated from Harper Adams University with a BSc degree in Animal Behaviour and Welfare and has successfully achieved a Gold Duke of Edinburgh Award in 2015.

Jon Melton

Graduated from the University of East Anglia with a BA Honours degree in Business Studies and his professional career began in the Insurance and Reinsurance industry in April 2000.  

In 2013, Jon co-founded Momentum Pharma where he holds the role of Chief Operating Officer (COO).

Jon’s career in (Re)Insurance has been wide-ranging in terms of activity and territory. He supported clients and sourced business globally at each stage of his career within the 3 largest global broking houses (Willis, Marsh and Aon). 

Jon also has an in-depth experience in Leadership, Project Management and global business transactions.

Melissa Melton

CEO of Momentum Pharma, possesses over 20 years of clinical research and development experience.  During this time, she has worked extensively in the field throughout the US, Canada, UK and Europe (Finland, Sweden, Belgium, Spain, France, Italy and Ireland). 

Melissa is a Senior Clinical Trial Consultant which roles include; Clinical Program Manager, Senior CRA, ICH/GCP Quality Assurance Consultant, and CRO Oversight Lead.  She has worked for global pharmaceutical giants such as: Roche and J&J, as well as CROs and multiple progressive, cutting-edge Biotech firms. 

Her experience is deep in a myriad of therapeutic areas including: adult and paediatric oncology, haematology, cardiovascular, central nervous system, rare genetic disease and more.  Melissa has been instrumental in relationship building with key opinion leaders, increasing global program development and risk assessment. 

During her expansive career, she has worked on multiple FDA/EMA block buster drugs including the first in class anti-retro viral for HIV (Fuzeon) and numerous life changing Oncology drugs (Avastin, Herceptin, Xeloda and Imbruvica).  Melissa holds a BA in Psychology from the University of Arizona.  She understands the Sponsor’s needs implicitly, her speciality is strategic plans of action for global development.

Dr Helen Buck

Dr. Helen Buck is Momentum’s Consulting Quality and Risk Assessment Manager. She brings to the team 25 years of clinical trials industry expertise and has developed the company’s Standard Operating Procedures (SOP) library, as well as many study plan templates.

Helen has worked on many aspects of clinical trials since starting her Consulting career in 2003 including medical writing and conduct of clinical programmes to ICH GCP guidelines among other roles. Dr. Helen Buck has a PhD in Neuroscience.